Opioid withdrawal symptoms can block your path to recovery.
LUCEMYRA® is the only FDA-approved, non-opioid medicine proven to help with symptoms of opioid withdrawal.
Photos within this website are actor portrayals.
LUCEMYRA can help relieve withdrawal symptoms
![](https://lucemyra.com/wp-content/uploads/2023/10/PictogramPapersCheck.png)
Significantly improves the percentage of patients who successfully complete withdrawal treatment
![](https://lucemyra.com/wp-content/uploads/2023/10/PictogramThumbsUp.png)
Demonstrated safety profile in studies
![](https://lucemyra.com/wp-content/uploads/2023/10/PictogramGraphDown.png)
Provides the biggest improvement in symptom relief when symptoms were often most severe
![CVA_Vignette_4c_0001_PG5 CVA_Vignette_4c_0001_PG5](https://lucemyra.com/wp-content/uploads/elementor/thumbs/CVA_Vignette_4c_0001_PG5-e1697725223187-qm9lfcej6598ozkgdapqrpxqbhbk7465p19mqiajc6.png)
Patient Resources
See a collection of interactive and downloadable content, and links to external organizations
LUCEMYRA PRESCRIPTION SAVINGS PROGRAM
Eligible patients will pay $0* for LUCEMYRA. *See Terms and Conditions for details
![](https://lucemyra.com/wp-content/uploads/2023/10/LUCEMYRABoxWithShadow.png)
2020 ASAM National Practice Guideline: Recommendations for Treating Opioid Withdrawal
The American Society of Addiction Medicine (ASAM) recognizes two main strategies for managing opioid withdrawal: gradually tapering the dose of the current opioid(s), or using a non-opioid medication, like LUCEMYRA (lofexidine).
Regarding the use of alpha-2 adrenergic agonists, the Guideline states:
“Lofexidine should therefore be the preferred choice for withdrawal management in an outpatient setting, where monitoring of blood pressure and management of hypotension is more difficult.”
-American Society of Addiction Medicine, 2020
Get Started with LUCEMYRA
Find a healthcare provider who can discuss treatment for opioid withdrawal symptoms with LUCEMYRA.
Photos within this website are actor portrayals.